Mubadala and Novo Holdings Invest €250m in Drug Discovery Firm Evotec

Mubadala Investment Company, Abu Dhabi’s strategic investment arm, and Novo Holdings, are investing €250 million ($295m) in drug discovery and development firm Evotec.

Read more…

Leave a Reply

Your email address will not be published. Required fields are marked *